Concomitant Use Of Propofol (Doe), Levobupivacaine (Doe), Noradrenaline (Doe), Dexcorfeniramine (Doe) And Abiraterone (Doe)

  Address - Spain

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 102786172

  Document Type - Tender Notices

Description - Description: Concomitant use of Propofol (DOE), Levobupivacaine (DOE), Noradrenaline (DOE), Dexcorfeniramine (DOE) and Abiraterone (DOE)local title:: Suministro de Propofol (DOE), Levobupivacaina (DOE), Noradrenalina (DOE) , Dexclorfeniramina (DOE) Y Abiraterona (DOE)Contract Duration: : 1 YEARContract Type: : Supplylocal description: : Suministro de Propofol (DOE), Levobupivacaina (DOE), Noradrenalina (DOE) , Dexclorfeniramina (DOE) Y Abiraterona (DOE) lot_details: 1: 1 - PROPOFOL (DOE) AL 0,5% (5 MG/ML), 2: 2 - PROPOFOL (DOE) AL 1% (10 MG/ML), 3: 3 - PROPOFOL (DOE) AL 2% (20 MG/ML), 4: 4 - LEVOBUPIVACAINE (DOE) SCHOLARSHIP, 5: 5 - LEVOBUPIVACAINE (DOE) PLASTIC AMPOULE, 6: 6 - LEVOBUPIVACAI

Gt Ref Id - 102786172

Deadline - Feb 20, 2025